These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 22708926

  • 1. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Schumm S, Sebban C, Cohen-Salmon C, Callebert J, Launay JM, Golmard JL, Boussicault L, Petropoulos I, Hild A, Rousselet E, Prigent A, Friguet B, Mariani J, Hirsch EC.
    J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926
    [Abstract] [Full Text] [Related]

  • 2. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M, Yokoyama H, Kato H, Araki T.
    Mol Cell Endocrinol; 2009 Nov 13; 311(1-2):62-8. PubMed ID: 19631714
    [Abstract] [Full Text] [Related]

  • 3. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.
    Pharmacol Biochem Behav; 2006 Mar 13; 83(3):349-59. PubMed ID: 16580056
    [Abstract] [Full Text] [Related]

  • 4. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 5. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 05; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 6. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T.
    Neuropharmacology; 2011 Dec 05; 61(8):1441-51. PubMed ID: 21903118
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T, Kadoguchi N, Kamiyama Y, Kato H, Maegawa H, Araki T.
    Neuropharmacology; 2006 Mar 05; 50(3):329-44. PubMed ID: 16303147
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K, Sedelis M, Auburger GW, Morgan S, Huston JP, Schwarting RK.
    Exp Neurol; 2001 Mar 05; 168(1):116-22. PubMed ID: 11170726
    [Abstract] [Full Text] [Related]

  • 9. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
    Oeckl P, Scheffold A, Lechel A, Rudolph KL, Ferger B.
    Neuroreport; 2014 Mar 26; 25(5):335-9. PubMed ID: 24525820
    [Abstract] [Full Text] [Related]

  • 10. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 26; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 26; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 26; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 13. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW.
    J Neurosci Res; 2006 Feb 01; 83(2):332-47. PubMed ID: 16385585
    [Abstract] [Full Text] [Related]

  • 14. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
    Gao L, Díaz-Martín J, Dillmann WH, López-Barneo J.
    Neuroscience; 2011 Oct 13; 193():323-9. PubMed ID: 21782904
    [Abstract] [Full Text] [Related]

  • 15. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
    Zhang HN, An CN, Zhang HN, Pu XP.
    Neurosci Lett; 2010 Apr 26; 474(2):99-103. PubMed ID: 20227465
    [Abstract] [Full Text] [Related]

  • 16. Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
    Muthian G, Mackey V, King J, Charlton CG.
    Neuroscience; 2010 Sep 01; 169(3):1085-93. PubMed ID: 20540993
    [Abstract] [Full Text] [Related]

  • 17. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice.
    Hamilton WR, Trickler WJ, Robinson BL, Paule MG, Ali SF.
    Neurosci Lett; 2012 May 02; 515(2):107-10. PubMed ID: 22414866
    [Abstract] [Full Text] [Related]

  • 18. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
    Oida Y, Kitaichi K, Nakayama H, Ito Y, Fujimoto Y, Shimazawa M, Nagai H, Hara H.
    Brain Res; 2006 Apr 12; 1082(1):196-204. PubMed ID: 16515773
    [Abstract] [Full Text] [Related]

  • 19. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
    Rojo AI, Montero C, Salazar M, Close RM, Fernández-Ruiz J, Sánchez-González MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A.
    Eur J Neurosci; 2006 Oct 12; 24(7):1874-84. PubMed ID: 17067291
    [Abstract] [Full Text] [Related]

  • 20. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR.
    Eur J Neurosci; 2009 Mar 12; 29(5):954-63. PubMed ID: 19245367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.